VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+1.58%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$79.7M
AUM Growth
-$662M
(-89%)
Cap. Flow
-$662M
Cap. Flow
% of AUM
-830.5%
Top 10 Holdings %
Top 10 Hldgs %
21.47%
Holding
291
New
144
Increased
52
Reduced
48
Closed
42
Top Buys
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$93.5M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
$65M |
| 3 |
BPL
Buckeye Partners, L.P.
BPL
|
$48.9M |
| 4 |
Energy Transfer Partners
ET
|
$45.2M |
| 5 |
Enterprise Products Partners
EPD
|
$40.2M |
Sector Composition
| 1 | Healthcare | 70.8% |
| 2 | Financials | 1.05% |
| 3 | Technology | 0.59% |
| 4 | Consumer Discretionary | 0.59% |
| 5 | Consumer Staples | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Theravance Biopharma
TBPH
$688M
| $974K | 1.22% |
34,929
+7,283
| +26% | +$203K |
|
27
BioMarin Pharmaceuticals
BMRN
$11.2B
| $973K | 1.22% |
10,910
-350
| -3% | -$31.2K |
|
28
Omeros
OMER
$278M
| $973K | 1.22% |
50,065
+2,953
| +6% | +$57.4K |
|
29
Incyte
INCY
$17.1B
| $967K | 1.21% |
10,205
+1,586
| +18% | +$150K |
|
|
MDCO
30
DELISTED
Medicines Co
MDCO
| $963K | 1.21% |
35,217
+8,157
| +30% | +$223K |
|
31
Puma Biotechnology
PBYI
$251M
| $955K | 1.2% |
9,661
+5,514
| +133% | +$545K |
|
32
Biogen
BIIB
$20.5B
| $953K | 1.2% |
2,990
-1,095
| -27% | -$349K |
|
33
Gilead Sciences
GILD
$141B
| $952K | 1.19% |
13,288
-2,638
| -17% | -$189K |
|
34
Regeneron Pharmaceuticals
REGN
$60.4B
| $950K | 1.19% |
2,526
+355
| +16% | +$134K |
|
35
Dynavax Technologies
DVAX
$1.2B
| $949K | 1.19% |
50,726
+19,405
| +62% | +$363K |
|
36
Lexicon Pharmaceuticals
LXRX
$385M
| $939K | 1.18% |
95,079
+75,607
| +388% | +$747K |
|
37
Ironwood Pharmaceuticals
IRWD
$185M
| $937K | 1.18% |
74,625
+4,960
| +7% | +$62.3K |
|
38
Ionis Pharmaceuticals
IONS
$9.64B
| $936K | 1.17% |
18,610
-1,765
| -9% | -$88.8K |
|
39
Travere Therapeutics
TVTX
$1.75B
| $933K | 1.17% |
44,297
-12,356
| -22% | -$260K |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $919K | 1.15% |
8,805
+254
| +3% | +$26.5K |
|
|
ICPT
41
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $908K | 1.14% |
15,542
+7,041
| +83% | +$411K |
|
42
Vanguard Real Estate ETF
VNQ
$34.3B
| $702K | 0.88% |
8,461
+750
| +10% | +$62.2K |
|
|
RXDX
43
DELISTED
Ignyta, Inc.
RXDX
| $612K | 0.77% |
22,936
-15,420
| -40% | -$411K |
|
|
LJPC
44
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $463K | 0.58% |
14,394
+2,549
| +22% | +$82K |
|
|
IMMU
45
DELISTED
Immunomedics Inc
IMMU
| $456K | 0.57% |
28,196
-14,588
| -34% | -$236K |
|
|
PVLA
46
Palvella Therapeutics, Inc. Common Stock
PVLA
$593M
| $432K | 0.54% |
+715
| New | +$432K |
|
47
iShares MSCI India ETF
INDA
$9.27B
| $427K | 0.54% |
+11,844
| New | +$427K |
|
|
XLRN
48
DELISTED
Acceleron Pharma Inc.
XLRN
| $414K | 0.52% |
9,748
-1,229
| -11% | -$52.2K |
|
|
ARRY
49
DELISTED
Array Biopharma Inc
ARRY
| $411K | 0.52% |
32,118
-10,118
| -24% | -$129K |
|
50
Regenxbio
RGNX
$482M
| $407K | 0.51% |
12,251
-5,020
| -29% | -$167K |
|